Seizert Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetApp
NTAP
|
+$25.6M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$22.5M |
| 3 |
Landstar System
LSTR
|
+$15.1M |
| 4 |
Expedia Group
EXPE
|
+$13.1M |
| 5 |
Skyworks Solutions
SWKS
|
+$3.94M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$17.7M |
| 2 |
Hewlett Packard
HPE
|
+$14.6M |
| 3 |
Assured Guaranty
AGO
|
+$14.5M |
| 4 |
Bankunited
BKU
|
+$14.4M |
| 5 |
Western Digital
WDC
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.02% |
| 2 | Healthcare | 17.47% |
| 3 | Financials | 15.51% |
| 4 | Industrials | 13.73% |
| 5 | Communication Services | 11.61% |
Similar funds
Seizert Capital Partners's Q3 2019 Portfolio in Review
As of Q3 2019, Seizert Capital Partners held 227 positions worth $1.98B, down 2.5% from $2.03B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Seizert Capital Partners withdrew a net $72.5M in Q3 2019, closing 27 positions and reducing 70 holdings. Its most notable exit was Hewlett Packard, an estimated $14.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Seizert Capital Partners opened a new position in Regeneron Pharmaceuticals worth $21.1M.
- Seizert Capital Partners's largest Q3 2019 buy was Regeneron Pharmaceuticals: 76,087 shares worth $21.1M.
- Seizert Capital Partners added most to NetApp in Q3 2019, an estimated $25.6M increase.
- Seizert Capital Partners's biggest Q3 2019 reduction was Celgene Corp, cutting an estimated $17.7M.
- Seizert Capital Partners fully exited Hewlett Packard in Q3 2019, selling an estimated $14.6M.
- Seizert Capital Partners's ten largest holdings make up 30% of its $1.98B portfolio in Q3 2019.
- Seizert Capital Partners opened 17 new positions and closed 27 in Q3 2019.
- Seizert Capital Partners's portfolio value fell 2.5% quarter-over-quarter to $1.98B.
Based on Seizert Capital Partners's 13F filing for Q3 2019, filed 7 Nov 2019.